SCHEMBL5595495

SCHEMBL5595495

c1ccc(-c2ccc(CNCCCN3CCNCC3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
SIGMAR1 Q99720 2/20 0.54
HDAC1 Q13547 1/20 0.52
DPP7 Q9UHL4 1/20 0.50
CXCR4 P61073 1/20 0.50
ALDH1A1 P00352 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
AKT1 P31749 1/20 0.45
AKT2 P31751 1/20 0.45
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2443705 0.90 DPP7 (0.57) CYP3A4CYP2D6HDAC1DPP7CYP2C19
SCHEMBL5605518 0.84 SLC2A1 (0.49) SMN1; SMN2
SCHEMBL5595644 0.83 CYP3A4 (0.57) CYP3A4CYP2D6SIGMAR1HDAC1CXCR4
SCHEMBL9048454 0.82 DPP7 (0.73) CYP3A4CYP2D6SIGMAR1DPP7CXCR4
SCHEMBL5604920 0.81 SLC6A4 (0.64) CYP3A4CYP2D6SIGMAR1HDAC1ALDH1A1
SCHEMBL2444736 0.80 DPP7 (0.69) CYP3A4CYP2D6SIGMAR1DPP7ALDH1A1
SCHEMBL14500262 0.80 DPP7 (0.69) CYP3A4CYP2D6SIGMAR1DPP7CXCR4
SCHEMBL5595516 0.80 CHRM2 (0.57) CYP3A4CYP2D6SIGMAR1CYP2C19CHRM2
SCHEMBL5595311 0.77 KCNJ1 (0.65) CYP3A4CYP2D6SIGMAR1HDAC1ALDH1A1
SCHEMBL5595232 0.76 CYP3A4 (0.47) CYP3A4CYP2D6SIGMAR1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809288-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2007-07-25 EP claimed
WO-2006051489-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2006-05-18 WO claimed